Termination of Temporary Deferment of Activities Relating to Biologics Submissions and Notice of New Mailing Address; Correction

Resumen

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 23, 1994 (59 FR 48895). The document announced the new address for submissions and identified the exact period which action on pending submissions was temporarily deferred. The agency also announced the installation of automated systems to make information available to the public and to help callers identify the new telephone numbers of Center for Biologics and Evaluation staff involved in review activities. The document was published with a typographical error. This document corrects that error.